BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22752853)

  • 1. GBM secretome induces transient transformation of human neural precursor cells.
    Venugopal C; Wang XS; Manoranjan B; McFarlane N; Nolte S; Li M; Murty N; Siu KW; Singh SK
    J Neurooncol; 2012 Sep; 109(3):457-66. PubMed ID: 22752853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
    Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
    J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMI1 sustains human glioblastoma multiforme stem cell renewal.
    Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
    J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.
    Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
    Stem Cells; 2011 Apr; 29(4):590-9. PubMed ID: 21360625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.
    Kelly JJ; Stechishin O; Chojnacki A; Lun X; Sun B; Senger DL; Forsyth P; Auer RN; Dunn JF; Cairncross JG; Parney IF; Weiss S
    Stem Cells; 2009 Aug; 27(8):1722-33. PubMed ID: 19544433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From neural stem cells to glioblastoma: A natural history of GBM recapitulated in vitro.
    Almengló C; Caamaño P; Fraga M; Devesa J; Costoya JA; Arce VM
    J Cell Physiol; 2021 Nov; 236(11):7390-7404. PubMed ID: 33959982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric glioblastoma cells inhibit neurogenesis and promote astrogenesis, phenotypic transformation and migration of human neural progenitor cells within cocultures.
    Farrell K; Mahajan G; Srinivasan P; Lee MY; Kothapalli CR
    Exp Cell Res; 2018 Jan; 362(1):159-171. PubMed ID: 29129566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity.
    Sarkar S; Poon CC; Mirzaei R; Rawji KS; Hader W; Bose P; Kelly J; Dunn JF; Yong VW
    Sci Rep; 2018 Oct; 8(1):15286. PubMed ID: 30327548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.
    Oliveira AI; Anjo SI; Vieira de Castro J; Serra SC; Salgado AJ; Manadas B; Costa BM
    Cell Commun Signal; 2017 Oct; 15(1):37. PubMed ID: 28969644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.
    Visnyei K; Onodera H; Damoiseaux R; Saigusa K; Petrosyan S; De Vries D; Ferrari D; Saxe J; Panosyan EH; Masterman-Smith M; Mottahedeh J; Bradley KA; Huang J; Sabatti C; Nakano I; Kornblum HI
    Mol Cancer Ther; 2011 Oct; 10(10):1818-28. PubMed ID: 21859839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
    Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
    Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
    J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma.
    Richichi C; Brescia P; Alberizzi V; Fornasari L; Pelicci G
    Neoplasia; 2013 Jul; 15(7):840-7. PubMed ID: 23814495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocytes enhance the invasion potential of glioblastoma stem-like cells.
    Rath BH; Fair JM; Jamal M; Camphausen K; Tofilon PJ
    PLoS One; 2013; 8(1):e54752. PubMed ID: 23349962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
    Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
    J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dystroglycan receptor maintains glioma stem cells in the vascular niche.
    Day BW; Lathia JD; Bruce ZC; D'Souza RCJ; Baumgartner U; Ensbey KS; Lim YC; Stringer BW; Akgül S; Offenhäuser C; Li Y; Jamieson PR; Smith FM; Jurd CLR; Robertson T; Inglis PL; Lwin Z; Jeffree RL; Johns TG; Bhat KPL; Rich JN; Campbell KP; Boyd AW
    Acta Neuropathol; 2019 Dec; 138(6):1033-1052. PubMed ID: 31463571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
    Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
    Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
    Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
    Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.